ICU Medical (ICUI) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
ICU Medical, Inc. Announces Second Quarter 2017 Results
August 9, 2017 4:05 PM EDTSAN CLEMENTE, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended June 30, 2017.
Second Quarter 2017 Results
Second quarter 2017 revenue was $331.5 million, compared to $96.7 million in the same period last year. GAAP gross profit for the second quarter of 2017 was $88.1 million, as compared to $50.1 million in the same period last year. GAAP gross margin for the second quarter... More
